Advances in immunotherapy in cervical cancer
Juan-Francisco Grau1, Lorena Farinas-Madrid1, Carmen Garcia-Duran1
1Gynaecologic Cancer Programme;Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Summary
Immunotherapy has transformed cervical cancer treatment, significantly improving survival for advanced stages. Research continues with novel approaches like vaccines and cell therapy for better patient outcomes.
Area of Science:
- Oncology
- Immunology
Background:
- Cervical cancer is a leading cause of death in women globally.
- Advanced cervical cancer (recurrent, persistent, metastatic) historically had poor prognosis with limited treatment options.
- Cisplatin-based chemotherapy plus bevacizumab was the standard for advanced disease.
Purpose of the Study:
- To review recent clinical trials on immunotherapy for cervical cancer.
- To highlight the impact of immune checkpoint inhibitors.
- To discuss emerging novel immunotherapy strategies.
Main Methods:
- Review of clinical trials in cervical cancer immunotherapy.
- Analysis of efficacy data from various treatment settings.
- Exploration of ongoing and future therapeutic developments.
Main Results:
- Immune checkpoint inhibitors have revolutionized cervical cancer treatment, showing significant survival improvements.
- Immunotherapy is being explored in the locally advanced setting with mixed preliminary results.
- Early-phase trials show promise for human papillomavirus (HPV) therapeutic vaccines and adoptive cell therapy.
Conclusions:
- Immunotherapy has dramatically improved outcomes for advanced cervical cancer.
- Further research is needed, especially in the locally advanced setting.
- Novel immunotherapy approaches hold future promise for cervical cancer patients.
Keywords:
cervical cancerMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
606
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
606
01:30Cancer Vaccines
463
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
463
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K